Esprit (ESPGY) Stock Chart & Stock Price History → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free ESPGY Stock Alerts $0.05 +0.01 (+24.84%) (As of 04/19/2024 ET) Add Compare Share Share ChartStock AnalysisChartDividendShort InterestStock AnalysisChartDividendShort Interest Esprit Stock Price Performance5 Day Performance-3.92%1 Month Performance-37.19%3 Month Performance-48.51%6 Month Performance-40.18%Year-To-Date Performance-52.93%1 Year Performance-61.93% Receive ESPGY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Esprit and its competitors with MarketBeat's FREE daily newsletter Email Address Ad AltimetrySecret Bull Market Starts in This Unusual Sector"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. ESPGY Stock Chart for Friday, April, 19, 2024 ESPGY Chart by TradingView Esprit Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/19/2024$0.05$0.05+11.67%$0.05$0.04139,331 shs$71.12 million04/18/2024$0.04$0.05+10.02%$0.05$0.045,118 shs$63.69 million04/17/2024$0.04$0.04-2.62%$0.04$0.045,310 shs$57.89 million04/16/2024$0.05$0.04-10.26%$0.04$0.041,578 shs$59.45 million04/15/2024$0.05$0.05-10.52%$0.05$0.0414,630 shs$66.24 million04/12/2024$0.05$0.05+4.81%$0.05$0.0470,776 shs$74.03 million Get the Latest News and Ratings for ESPGY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Esprit and its competitors with MarketBeat's FREE daily newsletter. 04/11/2024$0.05$0.05-7.42%$0.05$0.0517,997 shs$70.63 million04/10/2024$0.05$0.05+19.78%$0.06$0.04468,091 shs$76.29 million04/09/2024$0.05$0.05-3.43%$0.06$0.05261,358 shs$63.69 million04/08/2024$0.04$0.05+10.69%$0.05$0.04235,286 shs$65.96 million04/05/2024$0.04$0.04-1.03%$0.05$0.0449,615 shs$54.21 million04/04/2024$0.04$0.04$0.04$0.0431,313 shs$54.78 million04/03/2024$0.04$0.04+4.88%$0.04$0.0431,013 shs$54.78 million04/02/2024$0.05$0.04-18.36%$0.04$0.0497,572 shs$52.23 million04/01/2024$0.05$0.05-1.31%$0.05$0.0491,506 shs$63.98 million03/29/2024$0.05$0.05$0.05$0.04220,991 shs$64.83 million03/28/2024$0.05$0.05-1.93%$0.05$0.04220,991 shs$64.83 million03/27/2024$0.06$0.05-19.48%$0.05$0.0487,325 shs$66.10 million03/26/2024$0.07$0.06-13.82%$0.06$0.0521,584 shs$82.09 million03/25/2024$0.06$0.07+4.99%$0.07$0.079,932 shs$95.26 million03/22/2024$0.06$0.06+1.91%$0.07$0.065,079 shs$90.73 million03/21/2024$0.08$0.06-18.42%$0.08$0.0634,481 shs$89.03 million03/20/2024$0.08$0.08-3.63%$0.08$0.074,469 shs$109.13 million03/19/2024$0.07$0.08+8.84%$0.08$0.073,589 shs$113.23 million03/18/2024$0.08$0.07-3.54%$0.08$0.079,955 shs$104.03 million03/15/2024$0.07$0.07$0.07$0.0741,937 shs$102.76 million03/14/2024$0.07$0.07-1.22%$0.09$0.0741,769 shs$102.76 million03/13/2024$0.08$0.07-13.43%$0.09$0.06172,735 shs$104.03 million03/12/2024$0.08$0.08+10.12%$0.09$0.067,894 shs$120.17 million03/11/2024$0.08$0.08-2.03%$0.08$0.0723,079 shs$109.13 million03/08/2024$0.08$0.08-0.76%$0.08$0.074,941 shs$111.39 million03/07/2024$0.07$0.08+10.14%$0.08$0.08822 shs$112.24 million03/06/2024$0.08$0.07-6.61%$0.08$0.076,560 shs$101.91 million03/05/2024$0.07$0.08+10.14%$0.08$0.073,237 shs$109.13 million03/04/2024$0.07$0.07-4.11%$0.09$0.0738,625 shs$99.08 million03/01/2024$0.08$0.07-5.19%$0.07$0.071,666 shs$103.33 million02/29/2024$0.08$0.08+2.67%$0.08$0.08665 shs$108.99 million02/28/2024$0.07$0.08+4.31%$0.08$0.0722,389 shs$106.16 million02/27/2024$0.08$0.07-4.89%$0.07$0.075,227 shs$101.77 million02/26/2024$0.07$0.08+6.18%$0.08$0.072,415 shs$107.01 millionTiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>>02/23/2024$0.07$0.07-0.70%$0.09$0.0737,250 shs$100.78 million02/22/2024$0.08$0.07-10.38%$0.08$0.067,788 shs$101.49 million02/21/2024$0.08$0.08+1.14%$0.08$0.0810,269 shs$113.23 million02/20/2024$0.07$0.08+10.01%$0.08$0.081,403 shs$111.96 million02/19/2024$0.07$0.07$0.08$0.0720,300 shs$101.77 million02/16/2024$0.08$0.07-9.90%$0.08$0.0720,314 shs$101.77 million02/15/2024$0.07$0.08+14.00%$0.09$0.072,387 shs$112.95 million02/14/2024$0.09$0.07-17.65%$0.09$0.077,932 shs$99.08 million02/13/2024$0.09$0.09-4.71%$0.09$0.091,034 shs$120.31 million02/12/2024$0.09$0.09$0.09$0.092,291 shs$126.26 million02/09/2024$0.08$0.09+8.78%$0.09$0.08856 shs$126.26 million02/08/2024$0.08$0.08$0.10$0.0810,720 shs$116.06 million02/07/2024$0.09$0.08-4.54%$0.09$0.0510,720 shs$116.06 million02/06/2024$0.08$0.09+4.88%$0.09$0.091,281 shs$121.58 million02/05/2024$0.08$0.08+5.00%$0.09$0.0821,259 shs$115.92 million02/02/2024$0.09$0.08-11.96%$0.09$0.083,901 shs$110.40 million02/01/2024$0.08$0.09+8.45%$0.09$0.083,618 shs$125.41 million01/31/2024$0.08$0.08+4.88%$0.09$0.0817,903 shs$115.64 million01/30/2024$0.10$0.08-19.36%$0.09$0.0755,861 shs$110.26 million01/29/2024$0.10$0.10-3.16%$0.10$0.0815,870 shs$136.73 million01/26/2024$0.09$0.10+5.61%$0.10$0.10431 shs$141.26 million01/25/2024$0.09$0.09$0.10$0.082,240 shs$133.76 million01/24/2024$0.09$0.09+5.00%$0.10$0.092,240 shs$133.76 million01/23/2024$0.09$0.09-3.23%$0.10$0.085,500 shs$127.39 million01/22/2024$0.10$0.09-4.71%$0.10$0.0820,667 shs$131.63 million01/19/2024$0.08$0.10+15.78%$0.10$0.097,491 shs$138.14 million01/18/2024$0.09$0.08-0.82%$0.09$0.086,589 shs$119.32 million Related Companies: PKSGY Stock Price Chart NDLS Stock Price Chart LGCB Stock Price Chart FARM Stock Price Chart CLWY Stock Price Chart BGI Stock Price Chart LL Stock Price Chart LVLU Stock Price Chart ARKR Stock Price Chart BGFV Stock Price Chart Receive ESPGY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Esprit and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ESPGY) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlace1970’s computer coder issues shocking A.I. warningTradeSmithTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Esprit Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.